Back
SENTHILKUMAR RAMAMOORTHY
Glenmark Pharmaceuticals Ltd. – Appellant
Versus
Karlin Pharmaceuticals & Exports Private Limited – Respondent
JUDGMENT :
Senthilkumar Ramamoorthy, J.
[PRAYER : This Transfer Civil Miscellaneous Appeal (Trademarks) filed under Section 91 of the Trade Marks Act, 1999 in respect of goods falling in class 5, prays to:
(a) Allow the appeal of the Appellant, set aside the order dated 26/07/2013 of the Respondent No.2 herein, the Learned Deputy Registrar of Trade Marks, Mumbai passed in Opposition No.BOM-716540 to Application No.749366 in Class 5 and communicated vide Letter dated 07/01/2014 and allow the Opposition filed by the Appellant against the Respondent No.1 and thus render justice;
(b) the Respondent No.1 be asked to bear the cost of this proceedings under the provisions of Rule 19 of Intellectual Property Appellate Board (Procedure) Rules, 2003 read with paragraph (d) of sub-Section (2) of Section 92 of the Trade Marks Act, 1999 on the ground that (i) the Respondent No.1 has knowingly and deliberately with dishonest intention in bad faith adopted the impugned mark which is closely, confusingly and deceptively similar to the prior registered trade mark of the Appellant in relation to medicinal and/or pharmaceutical preparations and, (ii) the Respondent No.1 filed the impugned application in
The court established that prior use and the potential for public confusion are crucial in trademark registration disputes, particularly in the pharmaceutical industry.
The court established that the test for confusing similarity in pharmaceuticals is stringent, with prior registered marks holding superior rights that protect against consumer confusion.
The court ruled that the defendant's use of KIMIXIDE infringes the plaintiff's registered trademark AMIXIDE, being deceptively similar and likely to cause consumer confusion.
Prior use of a registered trademark grants exclusive rights, and honest concurrent use is not a defense in trademark infringement unless registered.
[The court established that in cases involving medicinal products, the threshold for proving deceptive similarity is lower due to the potential health risks associated with consumer confusion. The co....
The burden of proof on an ex-employee defendant in a trade mark infringement case and the relevance of uncontroverted evidence, such as the Court Commissioner's report, in establishing deceptive simi....
The central legal point established in the judgment is that in cases of trademark infringement, the likelihood of confusion and deception among the public must be supported by evidence. The court emp....
The use of a deceptively similar mark in the pharmaceutical industry can lead to confusion, warranting injunction to protect the registered trademark.
An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers
Please visit our Training & Support
Center or Contact Us for assistance
Scan Me!
India’s Legal research and Law Firm App, Download now!
For Daily Legal Updates, Join us on :
Back to top
